Larvol Delta - FDA-Accepts-Cingulates-New-Drug-Application-for-CTx1301-in-AttentionDecitHyperactivity-Disorder-ADHD-and-sets-a-May-31-2026-PDUFA-Date

dexmethylphenidate tri-modal release (CTx-1301) - Cingulate Therap

https://www.globenewswire.com/news-release/2025/10/14/3166151/0/en/FDA-Accepts-Cingulate-s-New-Drug-Application-for-CTx-1301-in-Attention-Deficit-Hyperactivity-Disorder-ADHD-and-sets-a-May-31-2026-PDUFA-Date.html

Oct 14, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next